4.3 Review

Current status and future perspectives of fluorescence-guided surgery for cancer

Journal

EXPERT REVIEW OF ANTICANCER THERAPY
Volume 16, Issue 1, Pages 71-81

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.2016.1121109

Keywords

Fluorescence-guided surgery (FGS); fluorophore; fluorescent proteins; photoimmunotherapy; theranostics

Categories

Funding

  1. National Cancer Institute [CA142669, CA132971]

Ask authors/readers for more resources

Curative cancer surgery is dependent on the removal of all primary tumor and metastatic cancer cells. Preoperative imaging, intraoperative inspection and palpation, as well as pathological margin confirmation aid the surgeon, but these methods are lacking in sensitivity and can be highly subjective. Techniques in fluorescence-guided surgery (FGS) are emerging that selectively illuminate cancer cells, enhancing the distinction between tumors and surrounding tissues with the potential for single-cell sensitivity. FGS enhances tumor detection, surgical navigation, margin confirmation, and in some cases can be combined with therapeutic techniques to eliminate microscopic disease. In this review, we describe the preclinical developments and currently-used techniques for FGS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available